Literature DB >> 28611997

The Burden of Hidradenitis Suppurativa in a Cohort of Patients in Southern Finland: A Pilot Study.

Nicolas Kluger1,2, Martta Ranta3, Martina Serlachius3.   

Abstract

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory disease that impacts the quality of life.
METHODS: We evaluated its burden in a cohort of 26 Finnish patients in a single-center cross-sectional study. Demographic data, disease history, clinical data, treatment patterns, and workability were collected. Patients responded to the Dermatology Life Quality Index (DLQI) and Beck Depression Inventory (BDI-21).
RESULTS: Mean age of HS patients was 44.2 years and mean diagnostic delay was 13.7 years. Pain was rated the most bothersome symptom. Mean DLQI score was 8.31. Women consistently had higher scores than men for every item of the DLQI. Mean BDI-21 score was 10.69. Higher Hurley stage at visit (p = 0.001), female gender (p = 0.018), and higher BDI-21 score (p = 0.022) were variables that significantly affected the total DLQI score, whereas female gender (p = 0.004) was the only variable that significantly affected the total BDI-21 score using stepwise regression analysis.
CONCLUSIONS: The burden of HS is for the first time reported in Finland. The diagnostic delay is longer than previously reported and the results suggest that women are impacted by the disease more than men.

Entities:  

Keywords:  Disease burden; Finland; Hidradenitis suppurativa; Quality of life

Year:  2017        PMID: 28611997      PMCID: PMC5465670          DOI: 10.1159/000455236

Source DB:  PubMed          Journal:  Skin Appendage Disord        ISSN: 2296-9160


  16 in total

1.  Pain in Hidradenitis Suppurativa: A Pilot Study.

Authors:  Hans C Ring; Henrik Sørensen; Iben M Miller; Emil K List; Ditte M Saunte; Gregor B Jemec
Journal:  Acta Derm Venereol       Date:  2016-05       Impact factor: 4.437

Review 2.  The Handicap of Hidradenitis Suppurativa.

Authors:  Inge Elizabeth Deckers; Alexa Boer Kimball
Journal:  Dermatol Clin       Date:  2015-09-14       Impact factor: 3.478

3.  Clinical Features and Patient Outcomes of Hidradenitis Suppurativa: A Cross-Sectional Retrospective Study.

Authors:  Whan B Kim; R Gary Sibbald; Howard Hu; Morteza Bashash; Niloofar Anooshirvani; Patricia Coutts; Afsaneh Alavi
Journal:  J Cutan Med Surg       Date:  2015-08-28       Impact factor: 2.092

4.  Diagnostic delay in hidradenitis suppurativa is a global problem.

Authors:  D M Saunte; J Boer; A Stratigos; J C Szepietowski; I Hamzavi; K H Kim; K Zarchi; C Antoniou; L Matusiak; H W Lim; M Williams; H H Kwon; M A Gürer; F Mammadova; A Kaminsky; E Prens; H H van der Zee; V Bettoli; S Zauli; J Hafner; S Lauchli; L E French; H Riad; M El-Domyati; H Abdel-Wahab; B Kirby; G Kelly; P Calderon; V del Marmol; F Benhadou; J Revuz; C C Zouboulis; I Karagiannidis; K Sartorius; L Hagströmer; E McMeniman; N Ong; M Dolenc-Voljc; Z B Mokos; L Borradori; R E Hunger; C Sladden; N Scheinfeld; N Moftah; L Emtestam; J Lapins; N Doss; I Kurokawa; G B E Jemec
Journal:  Br J Dermatol       Date:  2015-11-03       Impact factor: 9.302

5.  Development of a clinical Scandinavian registry for hidradenitis suppurativa; HISREG.

Authors:  Gisli Ingvarsson; Deidre Nathalie Dufour; Hassan Killasli; Karin Sartorius; Jan Lapins; Philip A Skau; Dagfinn Moseng; Darjosh Dinparvar; Anne-Sofie Furberg; Gregor B E Jemec; Lennart Emtestam
Journal:  Acta Derm Venereol       Date:  2013-05       Impact factor: 4.437

Review 6.  The psychosocial impact of hidradenitis suppurativa.

Authors:  Melinda Gooderham; Kim Papp
Journal:  J Am Acad Dermatol       Date:  2015-11       Impact factor: 11.527

7.  Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

Authors:  A Y Finlay; G K Khan
Journal:  Clin Exp Dermatol       Date:  1994-05       Impact factor: 3.470

8.  Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.

Authors:  Julia Shlyankevich; Allison J Chen; Grace E Kim; Alexandra B Kimball
Journal:  J Am Acad Dermatol       Date:  2014-10-14       Impact factor: 11.527

9.  Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies.

Authors:  Jean E Revuz; Florence Canoui-Poitrine; Pierre Wolkenstein; Cedric Viallette; Germaine Gabison; Florence Pouget; Florence Poli; Ousmane Faye; Jean Claude Roujeau; Genevieve Bonnelye; Jean Jacques Grob; Sylvie Bastuji-Garin
Journal:  J Am Acad Dermatol       Date:  2008-10       Impact factor: 11.527

10.  Hidradenitis suppurativa.

Authors:  J Revuz
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-09       Impact factor: 6.166

View more
  5 in total

1.  Hidradenitis Suppurativa: An Asian Perspective from a Singaporean Institute.

Authors:  Ellie Choi; Alex R Cook; Nisha Suyien Chandran
Journal:  Skin Appendage Disord       Date:  2018-01-26

2.  Health-Related Quality of Life of Patients with Hidradenitis Suppurativa Measured with the 15D Instrument and Comparison with the General Population and Patients with Psoriasis.

Authors:  Nicolas Kluger; Harri Sintonen; Martta Ranta; Martina Serlachius
Journal:  Skin Appendage Disord       Date:  2017-10-04

3.  Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients.

Authors:  Sylke Schneider-Burrus; Athanasia Tsaousi; Sebastian Barbus; Johannes Huss-Marp; Katrin Witte; Kerstin Wolk; Björn Fritz; Robert Sabat
Journal:  Front Med (Lausanne)       Date:  2021-04-27

4.  Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients.

Authors:  Piotr K Krajewski; Łukasz Matusiak; Esther von Stebut; Michael Schultheis; Uwe Kirschner; Georgios Nikolakis; Jacek C Szepietowski
Journal:  Life (Basel)       Date:  2021-01-08

5.  The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa.

Authors:  Alex Bató; Valentin Brodszky; L Hunor Gergely; Krisztián Gáspár; Norbert Wikonkál; Ágnes Kinyó; Ákos Szabó; Zsuzsanna Beretzky; Andrea Szegedi; Éva Remenyik; Norbert Kiss; Miklós Sárdy; Fanni Rencz
Journal:  Qual Life Res       Date:  2021-02-03       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.